share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰製藥 | 4：持股變動聲明-高管 Bozic Carmen
美股SEC公告 ·  06/13 16:15
Moomoo AI 已提取核心訊息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 12, 2024. The transaction was carried out in the open market with the shares sold at a price of $478.00 each, resulting in a total sale value of $1,089,840. Following the sale, Bozic's direct holdings in the company amount to 32,379 shares of common stock.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 12, 2024. The transaction was carried out in the open market with the shares sold at a price of $478.00 each, resulting in a total sale value of $1,089,840. Following the sale, Bozic's direct holdings in the company amount to 32,379 shares of common stock.
2024年6月12日，Vertex Pharmaceuticals Inc.（VRTX）的執行副總裁暨首席市場官Carmen Bozic出售了2,280股普通股。該交易在公開市場上進行，每股售價爲478.00美元，總售價爲1,089,840美元。此次出售後，Bozic在公司的直接持股爲32,379股普通股。
2024年6月12日，Vertex Pharmaceuticals Inc.（VRTX）的執行副總裁暨首席市場官Carmen Bozic出售了2,280股普通股。該交易在公開市場上進行，每股售價爲478.00美元，總售價爲1,089,840美元。此次出售後，Bozic在公司的直接持股爲32,379股普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息